Treatment of Fungal Corneal Ulcer with Hypopyon
Initiate topical natamycin 5% (NATACYN®) one drop hourly or every two hours as first-line therapy for fungal keratitis with hypopyon, and obtain corneal scrapings for culture and sensitivity testing before starting treatment to guide subsequent therapy. 1
Immediate Management Algorithm
Initial Diagnostic Steps
- Obtain corneal scrapings immediately using proparacaine 0.5% anesthetic (avoid tetracaine due to antimicrobial effects) from the base and periphery of the ulcer before initiating antifungal therapy 2, 3
- Inoculate samples directly onto fungal culture media (Sabouraud agar) and perform KOH/Calcofluor white staining to visualize fungal elements 2
- Do NOT tap the hypopyon - it is typically sterile in fungal keratitis unless there is concurrent endophthalmitis from trauma or surgery 2
First-Line Antifungal Therapy
Natamycin 5% is the only FDA-approved topical antifungal for fungal keratitis and should be started immediately 1:
- Loading phase: 1 drop hourly or every 2 hours for the first 3-4 days 1
- Maintenance phase: Reduce to 1 drop 6-8 times daily after initial improvement 1
- Duration: Continue for 14-21 days or until complete resolution of active infection 1
- Gradual taper: Reduce dosage at 4-7 day intervals to ensure organism elimination 1
Alternative and Adjunctive Antifungal Options
If natamycin fails or for specific organisms, consider these alternatives based on culture results:
- Voriconazole shows the lowest minimum inhibitory concentration (MIC) against most fungal pathogens and may be superior to natamycin, particularly for Aspergillus species 4, 5
- Amphotericin B 0.15-0.3% topical ointment or drops can be compounded for resistant cases, especially Aspergillus fumigatus and Fusarium solani 6
- Intracameral amphotericin B (5-10 μg/0.1 mL sterile water) or voriconazole (100 μg/0.1 mL) may be necessary for severe cases with deep stromal involvement 2, 5
Critical Management Considerations
Organism-Specific Treatment Adjustments
- Aspergillus species: Higher natamycin MIC values warrant early consideration of voriconazole or amphotericin B 4
- Fusarium species: Natamycin is FDA-approved specifically for Fusarium solani keratitis 1
- Candida species: May present with ring infiltrates and hypopyon; consider fluconazole 400-800 mg daily orally for susceptible isolates 2, 7
Adjunctive Medical Therapy
- Cycloplegics (atropine 1% or homatropine 5%) to reduce pain and prevent synechiae formation 3
- Oral doxycycline or minocycline (100 mg twice daily) to inhibit matrix metalloproteinases and reduce corneal melting risk 2
- AVOID topical corticosteroids initially - fungal keratitis has worse outcomes than bacterial keratitis with higher perforation rates 2
- Steroids may be considered cautiously only after definitive fungal identification, confirmed response to antifungals, and ruling out Nocardia 3, 5
Surgical Interventions for Complicated Cases
Indications for Surgical Management
Consider surgical intervention when:
- Progressive stromal thinning despite maximal medical therapy 2
- Impending or frank corneal perforation 2
- Large corneal perforation requiring structural support 2
- Unresponsive disease after 7-10 days of appropriate antifungal therapy 2
Surgical Options
- Amniotic membrane transplantation: May stabilize the ocular surface and improve outcomes, though it does not reduce hypopyon size or duration 2
- Therapeutic penetrating keratoplasty: For large perforations or progressive disease; send excised tissue for pathology and culture 2
- Tissue adhesive with bandage contact lens: For small perforations with good surrounding tissue 2
- Tenon's patch graft with cyanoacrylate glue: Effective for larger perforations 2
Monitoring and Follow-Up Protocol
- Daily examination initially until clear clinical improvement is documented 3
- Reassess at 3-4 days: If no improvement, reculture after stopping antifungals for 12-24 hours 2
- Expect slower healing: Fungal keratitis has slower re-epithelialization and higher perforation rates compared to bacterial keratitis 2
- Continue treatment for minimum 14-21 days even with clinical improvement to prevent relapse 1
Common Pitfalls to Avoid
- Do not delay corneal scraping - clinical differentiation between bacterial and fungal keratitis is correct in less than 70% of cases by experienced cornea specialists 2
- Do not use preserved anesthetics or cycloplegics before obtaining cultures as they reduce culture yield 2
- Do not start corticosteroids early - this is particularly dangerous in fungal keratitis and can lead to rapid progression 3, 5
- Do not assume natamycin will work for all fungi - Aspergillus species may require voriconazole or amphotericin B from the outset 4
- Do not stop treatment too early - gradual taper over 4-7 day intervals is essential to prevent recurrence 1
Fungal keratitis with hypopyon represents a sight-threatening emergency requiring aggressive initial therapy, close monitoring, and low threshold for surgical intervention given the higher perforation rates and worse visual outcomes compared to bacterial keratitis. 2